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arteriovenous malformation drains into branches of PVs or some-
times directly into the LA or inferior vena cava. They usually are
embedded to lung parenchyma.
In addition to causing shunt resulting in dyspnea, volume
overload, and cyanosis, PAVMs also cause the loss of ﬁlter func-
tion of lungs and thus may allow development of stroke and
cerebral abscess. The classic triad of dyspnea, cyanosis, and club-
bing is present in only 10% of cases.1
In our case, the lesion was producing high-output right-to-left
shunt and causing severe cyanosis. The aneurysm had a single large
feeding artery (afferent vessel) and no efferent vessel. Interestingly, it
was in continuity with the LA with an oriﬁce as big as the aneurysm
itself. In our knowledge no similar case has been reported in literature.
Traditional options for the deﬁnitive management of PAVM
include embolization and surgery. Ligation, local excision, seg-
mentectomy, lobectomy, or pneumonectomy have been per-
formed,1,2 although most of the time parenchyme-saving opera-
tions are preferred.
It was obvious that embolization would be inappropriate for
this case not only because leaving a residual aneurysm would
result in a high risk of rupture but also because of the unsuitable
anatomy of the feeding artery. During preoperative evaluation we
considered 2 possible approaches for surgical treatment of this
PAVM. Instead of median sternotomy and repair through the LA
with cardiopulmonary bypass and cardiac arrest, we used simple
ligation and resection through thoracotomy, which allowed better
exposure, a shorter operation, and faster recovery. We believe the
origin of this sac would be one of the following: an aneurysmal
PAVM with draining vessel was absorbed in time and united
widely to the LA, or a distal PA aneurysm ruptured and united to
the LA. Unusual features like extraparenchymal location of the
lesion, absence of an efferent vessel, unity of aneurysmal sac with
the LA, and the absence of associated etiologic factors make this
lesion interesting. Nonetheless, prompt surgical treatment with a
simple approach relieved the severe symptoms and prevented a
potential fatal rupture.
In conclusion, although PAVMs are rare, they should be in-
cluded in any differential diagnosis of worsening dyspnea, cyano-
sis, stroke, or hemoptysis. Their presence should be considered
especially in patients with cyanosis whom no evidence of intra-
cardiac shunts in echocardiography. Prompt workup and interven-
tion can prevent fatal complications like rupture and lead to
dramatic improvement in symptoms.
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Use of the endoclamp device in a patient with a native mitral
valve endocarditis and a previous arch replacement with a modiﬁed
Griepp technique
Siamak Mohammadi, MD, Pierre Voisine, MD, Patrick Mathieu, MD, and François Dagenais, MD, Québec City, Canada
Development of new catheters and cannulas has al-lowed accessing the heart through short incisions. Useof this technology may also be applied for difﬁcultreoperative situations. We herein report the use of the
endoclamp in a patient with a previous root and arch replacement
requiring mitral surgery for a native mitral endocarditis.
Clinical Summary
A 58-year-old male was admitted with asthenia, weight loss,
and fever. His past medical history was positive for hyper-
tension, diabetes, peripheral vascular disease (aortobifemoral
graft). The patient had a root replacement with a Bjork-Shiley
conduit in 1982 for a type A dissection. The patient also had an
arch replacement using an isolated graft to the arch vessels
(modiﬁed Greipp technique) and an “elephant trunk” procedure
in 2001 with a right axillary artery cannulation. The patient
also required a replacement of his thoracoabdominal aorta in
May 2002.
Transthoracic echocardiography revealed a moderate mitral
regurgitation and a 3.5-cm vegetation on the posterior leaﬂet. No
vegetation was documented on the Bjork-Shiley aortic prosthesis.
Blood cultures grew Staphylococcus epidermidis. Owing to his poor
overall condition, the patient was treated with vancomycin and
rifampycin although the embolic risk was present. Absence of
dacron graft infection was suggested by a normal gallium scan and
magnetic resonance imaging.
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Following a 4-week antibiotic course, the patient’s overall
condition improved and a reoperation was considered. Repeat
echocardiography showed similar ﬁndings. An approach through
the right chest was selected owing to the multiple grafts. To
optimize exposure of the mitral valve with an aortic prosthesis,
decompression of the aortic root was considered to be preferable.
To initiate aortic crossclamping and root decompression, an en-
doclamp was inserted in the Y port of the arterial cannula (Car-
diovations, Somerville, NJ) of the right limb of the aortobifemoral
graft (Figure 1). Owing to the limited space to fully inﬂate the
endoclamp between the arch graft and the aortic valve (Figure 2),
cerebral perfusion was ensured by recannulating the right axillary
artery. A pulmonary vent (Cardiovations) was inserted through the
right jugular vein. The endoclamp was inﬂated under transesoph-
ageal echocardiography guidance just above the aortic valve thus
covering the arch vessel graft. Cardioplegia and root decompres-
sion were conducted through the endoclamp ports. The left atrium
was opened and adequate exposure of the mitral valve obtained.
The vegetation was localized on the posterior leaﬂet. The mitral
valve was replaced with a mechanical prosthesis. Total aortic
crossclamp and cardiopulmonary bypass times were 88 and 113
minutes, respectively. Postoperatively, the patient developed a right
pleural effusion necessitating 2 pleurodeses. At 8-month follow-up,
the patient is well and free of infection.
Discussion
Mideline chest reentry for mitral surgery with previous proximal
aortic surgery can be hazardous. In such circumstances, the right
anterolateral thoracotomy has been shown to be safe and effective.1,2
During the last decade, minimal access of the mitral valve has
been advocated either with or without the port-access platform. Ex-
cellent results have been reported with minimal access mitral proce-
dures even in previously operated patients.3 The present case illus-
trates the use of the port-access platform in a complex case with
multiple previous thoracic aortic surgeries. Because a redo sternotomy
was judged prohibitive, access through the untouched right chest, as
opposed to the left chest, seemed the easiest and safest approach.
Although mitral surgery through the right chest under ventricular
ﬁbrillation or on the beating heart has been reported,4 the presence of
a mechanical valve with a pressurized root may limit exposure of the
mitral valve. To obviate this problem, insertion of an endoclamp
through the femoral cannula allowed arresting the heart and venting
the aortic root. However, the distance between the aortic prosthesis
and the takeoff of the arch graft did not permit safe inﬂation of the
endoclamp. To ensure adequate arch vessel perfusion, the right axil-
lary artery was reused. We have previously reported the feasibility
and the safety of recannulating the right axillary artery.5 Other pos-
sible options could have been to cannulate the right brachial artery or
the left axillary artery.
In summary, we report a unique case of mitral valve surgery
with previous multiple aortic surgeries including an arch replace-
ment with a modiﬁed Griepp technique. Use of the port-access
technology enabled us to arrest the heart and vent the aortic root.
Figure 1. Sketch showing the endoclamp position and the arterial
perfusion through the right limb of the aortobifemoral graft and
the right axillary artery.
Figure 2. Aortogram demonstrating the narrow space between
the arch graft and the aortic valve.
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In case of an isolated graft to the arch vessel, one should ensure
sufﬁcient space to inﬂate the endoclamp without compromising ce-
rebral perfusion. If uncertain, one should consider cannulating the
brachial or axillary artery to perfuse the brain during the endoclamp
inﬂation.
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Ventricular assist device use for the treatment of acute viral
myocarditis
Veli K. Topkara, MD, Nicholas C. Dang, MD, Fabio Barili, MD, Timothy P. Martens, MD, Isaac George, MD,
Faisal H. Cheema, MD, Hasmet Bardakci, MD, Ali Vefa Ozcan, MD, and Yoshifumi Naka, MD, PhD, New York, NY
Acute viral myocarditis is a rare condition and associ-ated with high mortality due to the rapid developmentof heart failure. Ventricular assist devices (VADs)have become a life-saving approach for patients with
acute viral myocarditis who are otherwise refractory to the aggres-
sive medical therapy.1,2 We reviewed our institutional experience
to evaluate the use of VADs as a treatment option for viral
myocarditis.
Patients and Methods
From January 1995 to March 2005, 11 patients underwent VAD
implantation (left VAD [LVAD] in 10, biventricular assist device
[BIVAD] in 1) for acute viral myocarditis at Columbia-Presbyterian
Medical Center. Patients were evaluated with regards to demo-
graphics, presenting symptoms, histological manifestations, and
electrocardiographic ﬁndings. Outcome variables included bridge-
to-transplantation rate and long-term survival. Data was collected
by retrospective chart review.
Results
The mean age of the population was 33.8  14.2 years. None of
the patients had a previous history of cardiac disease. Prodromal
symptoms preceding the onset of myocarditis included ﬂulike
symptoms, chest pain, syncope, and varicella syndrome (Table 1).
All patients were transferred from outside institutions with diag-
noses of decompensated heart failure complicating acute viral
myocarditis. The diagnosis of viral myocarditis was primarily
based on clinical presentation and histologic ﬁndings and sup-
ported by viral serology and culture. Viral pathogens were isolated
only in 6 of the 11 patients (Table 2). Histologic evidence of acute
myocarditis using the Dallas Criteria was present in 8 patients
(72.7%); only cellular inﬁltrate was found in the remaining pa-
tients.3 At the time of admission to our center, 4 patients were
temporarily supported by either intra-aortic balloon pump (n  3)
or extracorporeal membrane oxygenation (ECMO; n  1). All
patients had electrocardiographic abnormalities including sinus
tachycardia, diffuse nonspeciﬁc repolarization abnormalities, and
bundle branch block.
LVAD was used as the sole support system in 8 patients with
left ventricular failure. BIVAD was temporarily implanted in 2
patients with biventricular failure and was switched to LVAD after
recovery of right ventricular function. One patient was bridged to
transplant using BIVAD alone without the necessity for LVAD.
There were no operative mortalities (0.0%). Nine patients
had postoperative complications including acute renal failure, right
heart failure, reoperation for bleeding, pericardiocentesis for car-
diac tamponade, and sepsis (Table 1). The mean duration of VAD
support was 58.4  91.7 days (range 5-324 days). Four patients
(36.4%) died in-hospital on VAD support with a mean survival of
12  6 postoperative days. Causes of death for these patients
included right heart failure (n  2), sepsis (n  1), and multiorgan
failure (n  1). The mean preoperative LVAD score was signiﬁ-
cantly higher in patients who died compared with those who
survived (6.3  1.3 vs 3.5  1.9, P  .034).4 Of the 7 surviving
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